Indolent or Intermediate Grade B-cell Malignancy
specific1
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Indolent or Intermediate Grade B-cell Malignancy(1)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 100.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →